CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response

por Wegman, Pia P, Wingren, Sten
Publicado 2005

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

por Wegman, Pia, Elingarami, Sauli, Carstensen, John, Stål, Olle, Nordenskjöld, Bo, Wingren, Sten
Publicado 2007

The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors

por Tina, Elisabet, Lindqvist, Breezy Malakkaran, Gabrielson, Marike, Lubovac, Zelmina, Wegman, Pia, Wingren, Sten
Publicado 2012

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

por Wegman, Pia, Vainikka, Linda, Stål, Olle, Nordenskjöld, Bo, Skoog, Lambert, Rutqvist, Lars-Erik, Wingren, Sten
Publicado 2005

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab

por Ellegård, Sander, Veenstra, Cynthia, Pérez-Tenorio, Gizeh, Fagerström, Victor, Gårsjö, Jon, Gert, Krista, Sundquist, Marie, Malmström, Annika, Wingren, Sten, Elander, Nils O., Hallbeck, Anna-Lotta, Stål, Olle
Publicado 2019